COMMUNIQUÉS West-GlobeNewswire

Extendicare Announces 2019 Second Quarter Results
14/08/2019
MARKHAM, Ontario, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2019. Results are presented in Canadian [...]
Fibrocell Reports Second Quarter 2019 Financial Results and Recent Operational Highlights
14/08/2019
- Company to Host Conference Call and Webcast on Thursday, August 15 at 8:30 a.m. EDT - EXTON, Pa., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on [...]
Pacific Health Care Organization, Inc. Reports Second Quarter 2019 Results
14/08/2019
Newport Beach, CA, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its quarterly report [...]
Sienna Senior Living Inc. Reports 2019 Second Quarter Financial Results and Announces 2% Dividend Increase
14/08/2019
MARKHAM, Ontario, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced its financial results for the three and six months ended June 30, 2019. The [...]
T2 Biosystems Reports Granting of Inducement Awards
14/08/2019
LEXINGTON, Mass., Aug. 14, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
Precision BioSciences Reports Second Quarter 2019 Financial Results and Highlights Ongoing Operational Progress
14/08/2019
DURHAM, N.C., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life through the application of its pioneering, proprietary ARCUS [...]
SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2019 Financial Results
14/08/2019
- Multiple Clinical Milestones and Data Sets Expected by Year End / Q1 2020 - - Company to Host its First R&D Investor Day in Q4 2019 - NEW YORK, Aug. 14, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. ( [...]
Outlook Therapeutics Provides Business Update and Reports Financial Results for Third Quarter of Fiscal 2019
14/08/2019
CRANBURY, N.J., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the “Company”) today reported business highlights and financial results for its third quarter ended June 30, 2019. Recent [...]
Emergent BioSolutions to Participate in Series of Investor Conferences
14/08/2019
GAITHERSBURG, Md., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences [...]
UPDATE – North American Partners in Anesthesia (NAPA) welcomes Dan Gofman as new Senior Vice President of Mergers & Acquisitions
14/08/2019
MELVILLE, N.Y., Aug. 14, 2019 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) , one of the leading single-specialty anesthesia and perioperative management companies in the US, today announced that Dan [...]
NeuBase Therapeutics Reports Financial Results for the Fiscal Third Quarter of 2019
14/08/2019
Completed two financings in July 2019 totaling approximately $14 million in gross proceeds with participation from institutional investors including Greenlight Capital PITTSBURGH, Aug. 14, 2019 (GLOBE NEWSWIRE) -- [...]
Zosano Pharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update
14/08/2019
Conference call scheduled for 1:30 p.m. PT today FREMONT, Calif., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results [...]
Y-mAbs Announces Second Quarter 2019 Financial Results and Recent Corporate Developments
14/08/2019
NEW YORK, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel [...]
Beyond Air™ Reports Financial Results for Fiscal First Quarter 2020
14/08/2019
Began trading under new ticker symbol, XAIR, on the NASDAQ stock exchange on July 15, 2019 Anticipate submitting a PMA for LungFit ™ * for the treatment of persistent pulmonary hypertension of the newborn (PPHN) in the [...]
SeaSpine Announces Launch of Mariner® MIS Posterior Fixation System
14/08/2019
CARLSBAD, Calif., Aug. 14, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]
Misonix Reports Fourth Quarter and Fiscal Year 2019 Results
14/08/2019
FARMINGDALE, N.Y., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Daré Bioscience Reports Second Quarter 2019 Financial Results and Company Update
14/08/2019
SAN DIEGO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the second quarter ended June 30, 2019 and provided a [...]
Harrow Health Announces Second Quarter 2019 Results
14/08/2019
Consolidated quarterly revenues reach new record of $13.5 million NASHVILLE, Tenn., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the second quarter 2019. Second Quarter [...]
Profound Medical Announces Second Quarter 2019 Financial Results
14/08/2019
TORONTO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]

Pages